The Ministry of Chemicals and Fertilizers on 1st June 2021 has issued the operational guidelines for the Production Linked Incentive (PLI) Scheme for Pharmaceuticals. The scheme envisages to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains.
The Ministry has Invited applications three groups based on the Global Manufacturing Revenue of FY 2019-20 of the applicants. A special carve out for MSMEs has been kept under the scheme.
The application shall be made on the online portal, URL of which is https://pli-pharma.udyamimitra.in. The application window is for 60 days starting from 2nd June, 2021 to 31st July, 2021.
The products covered under the scheme are formulations, biopharmaceuticals, active pharmaceutical ingredients, key starting material, drug intermediates, in-vitro diagnostic medical devices, etc.
The selected manufacturers will be able to receive production linked incentives based on incremental sales of pharmaceutical products for a period of 6 years. A selected participant will be able to get a maximum incentive of Rs 1000 crore, Rs 250 crore and Rs 50 crore respectively depending upon its group over the period of the scheme.
